The Hormone Puzzle: Decoding the what, when and how long of hormone replacement therapy in women

In this interview, Leslie Cho, MD, FACC, and Steven E. Nissen MD, MACC explore the nuances of estrogen and testosterone replacement: who benefits, when to consider it, and how long it should last.

Related References:

  1. Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N., Shifren, J. L., Shufelt, C. L., Stuenkel, C. A., Lindley, K. J., & ACC CVD in Women Committee (2023). Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?. Circulation, 147(7), 597–610.
  2. Lincoff, A. M., Bhasin, S., Flevaris, P., Mitchell, L. M., Basaria, S., Boden, W. E., Cunningham, G. R., Granger, C. B., Khera, M., Thompson, I. M., Jr, Wang, Q., Wolski, K., Davey, D., Kalahasti, V., Khan, N., Miller, M. G., Snabes, M. C., Chan, A., Dubcenco, E., Li, X., … TRAVERSE Study Investigators (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. The New England journal of medicine, 389(2), 107–117.

Keywords: ACCELLite, Testosterone, ACC Annual Scientific Session, ACC24

< Back to Listings